Medpace Holdings, Inc.

MEDP Healthcare Diagnostics & Research

Medpace Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 20.0% from fiscal 2024.

Revenue
+8.50%
EPS
+24.6%
Free cash flow
−16.6%

Quarter to September 2026, against a year earlier

654.77 19.79 +3.12%
Market cap
$17.8B
P/E
34.6×
Fwd P/E
35.8×
Dividend yield
—
F-score
8/9
Altman Z
8.04
Beneish M
−2.92
Dividend safety
n/a
Older periods Dec '25 Mar '26 Jun '26 Sep '26
Piotroski F-Score

+8 more TTM periods

8 9 9 9
ROE
70.23% 77.25% 162.15% 117.88%
ROA
22.13% 22.87% 27.09% 25.54%
ROIC
0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
(202.23%) (663.29%) (215.54%) (680.52%)
Average Days of Receivables
58.00 53.77 57.96 57.56
Free Cash Flow per Share
23.64 25.00 25.08 23.90
Free Cash Flow
681.87 711.00 706.69 667.63
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026